Skip to main content

Advertisement

Log in

Higher serum phosphorus predicts residual renal function loss in male but not female incident peritoneal dialysis patients

  • Original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Elevated serum phosphorus level is a risk factor for progression of chronic kidney disease in non-dialysis patients. However, the association of serum phosphorus level with residual renal function (RRF) loss among incident continuous ambulatory peritoneal dialysis (CAPD) patients remains unclear.

Methods

We performed a retrospective analysis of prospectively collected cohort of 1245 incident CAPD patients from January 2006 to December 2015 and followed up until December 2017. Patients were stratified into tertiles according to baseline serum phosphorus levels. RRF loss was defined as residual glomerular filtration rate (mL/min/1.73 m2) reaching zero or estimated urine output less than 200 mL/day on two successive clinic visits. Propensity-score matched Cox’s proportional hazards and competing risk models were performed to examine the association of serum phosphorus with RRF loss.

Results

A total of 421 (33.82%) patients had loss of RRF over a median follow-up of 26.23 months. In the entire cohort, elevated serum phosphorus was associated with increased risk for RRF loss after adjustment. In the propensity-score matched cohort, patients in the 3rd tertile of serum phosphorus had a 51% higher risk of RRF loss than those in the combination of the 1st and 2nd tertiles. Furthermore, the association of serum phosphorus level with RRF loss differed by sex (interaction P = 0.018). The adjusted HRs per 1 mg/dL increase in serum phosphorus level of RRF loss were 1.32 (95% CI 1.15–1.50, P < 0.001) for male and 1.03 (95% CI 0.87–1.21, P = 0.750) for female, respectively. These findings persisted in competing risk analysis.

Conclusion

Higher serum phosphorus levels independently predicts RRF loss in men treated with CAPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56(2):348–358. https://doi.org/10.1053/j.ajkd.2010.03.020

    Article  PubMed  PubMed Central  Google Scholar 

  2. Toth-Manikowski SM, Sirich TL, Meyer TW, Hostetter TH, Hwang S, Plummer NS, Hai X, Coresh J, Powe NR, Shafi T (2019) Contribution of ‘clinically negligible’ residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz042

    Article  PubMed Central  Google Scholar 

  3. Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90(2):262–271. https://doi.org/10.1016/j.kint.2016.02.037

    Article  PubMed  PubMed Central  Google Scholar 

  4. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2016) Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol 27(12):3758–3768. https://doi.org/10.1681/asn.2015101142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Krediet RT (2017) Preservation of residual kidney function and urine volume in patients on dialysis. Clin J Am Soc Nephrol 12(3):377–379. https://doi.org/10.2215/CJN.00330117

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang AY, Lai KN (2006) The importance of residual renal function in dialysis patients. Kidney Int 69(10):1726–1732. https://doi.org/10.1038/sj.ki.5000382

    Article  PubMed  Google Scholar 

  7. Perl J, Bargman JM (2009) The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis 53(6):1068–1081. https://doi.org/10.1053/j.ajkd.2009.02.012

    Article  PubMed  Google Scholar 

  8. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP (2006) Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1(4):825–831. https://doi.org/10.2215/CJN.02101205

    Article  CAS  PubMed  Google Scholar 

  9. O’Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS (2011) Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 26(9):2885–2890. https://doi.org/10.1093/ndt/gfq808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. De Nicola L, Conte G, Chiodini P, D’Angio P, Donnarumma G, Minutolo R (2014) Interaction between phosphorus and parathyroid hormone in non-dialysis CKD patients under nephrology care. J Nephrol 27(1):57–63. https://doi.org/10.1007/s40620-013-0001-8

    Article  CAS  PubMed  Google Scholar 

  11. Thongprayoon C, Cheungpasitporn W, Mao MA, Sakhuja A, Erickson SB (2018) Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients. J Nephrol 31(2):241–247. https://doi.org/10.1007/s40620-017-0442-6

    Article  CAS  PubMed  Google Scholar 

  12. Kasiske BL, Lakatua JD, Ma JZ, Louis TA (1998) A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31(6):954–961. https://doi.org/10.1053/ajkd.1998.v31.pm9631839

    Article  CAS  PubMed  Google Scholar 

  13. Fouque D, Laville M (2009) Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Systematic Rev. https://doi.org/10.1002/14651858.cd001892.pub3

    Article  Google Scholar 

  14. Yoon CY, Park JT, Jhee JH, Noh J, Kee YK, Seo C, Lee M, Cha MU, Kim H, Park S, Yun HR, Jung SY, Han SH, Yoo TH, Kang SW (2017) High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study. Am J Clin Nutr 106(1):311–321. https://doi.org/10.3945/ajcn.116.151654

    Article  CAS  PubMed  Google Scholar 

  15. Coladonato JA (2005) Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 16(Suppl 2):S107–S114. https://doi.org/10.1681/asn.2005060663

    Article  CAS  PubMed  Google Scholar 

  16. He L, Liu X, Li Z, Abreu Z, Malavade T, Lok CE, Bargman JM (2016) Rate of decline of residual kidney function before and after the start of peritoneal dialysis. Perit Dial Int 36(3):334–339. https://doi.org/10.3747/pdi.2016.00024

    Article  PubMed  PubMed Central  Google Scholar 

  17. Noordzij M, Voormolen NM, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Korevaar JC, Group Ns (2009) Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. Nephrol Dial Transplant 24(5):1580–1587. https://doi.org/10.1093/ndt/gfn768

    Article  CAS  PubMed  Google Scholar 

  18. Bai W, Li J, Liu J (2016) Serum phosphorus, cardiovascular and all-cause mortality in the general population: a meta-analysis. Clin Chim Acta 461:76–82. https://doi.org/10.1016/j.cca.2016.07.020

    Article  CAS  PubMed  Google Scholar 

  19. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE (2000) Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11(3):556–564

    CAS  PubMed  Google Scholar 

  20. de Jager DJ, Halbesma N, Krediet RT, Boeschoten EW, le Cessie S, Dekker FW, Grootendorst DC (2013) Is the decline of renal function different before and after the start of dialysis? Nephrol Dial Transplant 28(3):698–705. https://doi.org/10.1093/ndt/gfs578

    Article  CAS  PubMed  Google Scholar 

  21. Noordzij M, Leffondre K, van Stralen KJ, Zoccali C, Dekker FW, Jager KJ (2013) When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant 28(11):2670–2677. https://doi.org/10.1093/ndt/gft355

    Article  PubMed  Google Scholar 

  22. Sim JJ, Bhandari SK, Smith N, Chung J, Liu IL, Jacobsen SJ, Kalantar-Zadeh K (2013) Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 126(4):311–318. https://doi.org/10.1016/j.amjmed.2012.08.018

    Article  CAS  PubMed  Google Scholar 

  23. Bellasi A, Mandreoli M, Baldrati L, Corradini M, Di Nicolo P, Malmusi G, Santoro A (2011) Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 6(4):883–891. https://doi.org/10.2215/CJN.07810910

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW, Group Ps (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22(10):2909–2916. https://doi.org/10.1093/ndt/gfm286

    Article  CAS  PubMed  Google Scholar 

  25. Smith DH, Johnson ES, Thorp ML, Petrik A, Yang X, Blough DK (2010) Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study. Nephrol Dial Transplant 25(1):166–174. https://doi.org/10.1093/ndt/gfp387

    Article  CAS  PubMed  Google Scholar 

  26. Chue CD, Edwards NC, Davis LJ, Steeds RP, Townend JN, Ferro CJ (2011) Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant 26(8):2576–2582. https://doi.org/10.1093/ndt/gfq787

    Article  CAS  PubMed  Google Scholar 

  27. Cirillo M, Ciacci C, De Santo NG (2008) Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 359(8):864–866. https://doi.org/10.1056/NEJMc0800696

    Article  CAS  PubMed  Google Scholar 

  28. Ix JH, Chonchol M, Laughlin GA, Shlipak MG, Whooley MA (2011) Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis 58(5):737–745. https://doi.org/10.1053/j.ajkd.2011.06.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Onufrak SJ, Bellasi A, Cardarelli F, Vaccarino V, Muntner P, Shaw LJ, Raggi P (2009) Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol 169(1):67–77. https://doi.org/10.1093/aje/kwn285

    Article  PubMed  Google Scholar 

  30. Yoo KD, Kang S, Choi Y, Yang SH, Heo NJ, Chin HJ, Oh KH, Joo KW, Kim YS, Lee H (2016) Sex, age, and the association of serum phosphorus with all-cause mortality in adults with normal kidney function. Am J Kidney Dis 67(1):79–88. https://doi.org/10.1053/j.ajkd.2015.06.027

    Article  CAS  PubMed  Google Scholar 

  31. Saab G, Whooley MA, Schiller NB, Ix JH (2010) Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study. Am J Kidney Dis 56(3):496–505. https://doi.org/10.1053/j.ajkd.2010.03.030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ibels LS, Alfrey AC, Haut L, Huffer WE (1978) Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 298(3):122–126. https://doi.org/10.1056/nejm197801192980302

    Article  CAS  PubMed  Google Scholar 

  33. Komaba H, Fukagawa M (2016) Phosphate-a poison for humans? Kidney Int 90(4):753–763. https://doi.org/10.1016/j.kint.2016.03.039

    Article  CAS  PubMed  Google Scholar 

  34. Razzaque MS (2011) Phosphate toxicity: new insights into an old problem. Clinical science (London, England: 1979) 120(3):91–97. https://doi.org/10.1042/cs20100377

    Article  CAS  Google Scholar 

  35. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T (2014) Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306(12):F1418–F1428. https://doi.org/10.1152/ajprenal.00633.2013

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from the Guangzhou Committee of Science and Technology, China (2010U1-E00831), the PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (S2013040012953), Key Laboratory of Nephrology, Guangdong Province, Guangzhou, China (2002B60118), and Operational Grant of Guangdong Provincial Key Laboratory (2017B030314019).

Author information

Authors and Affiliations

Authors

Contributions

HPM, JNS and WL contributed to the study conception and design. JNS and WL performed analyses of data, interpretation of data and drafting manuscript. YTW, HYL, JLW, ZZ and YZK contributed to data collection and manuscript revision. HPM, XFH, and XQY provided overall supervision.

Corresponding author

Correspondence to Haiping Mao.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethics approval and consent to participate

All participants provided written informed consents. The study was approved by the First Affiliated Hospital of Sun Yat-sen University Institutional Review Boards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

40620_2019_670_MOESM1_ESM.docx

Supplementary material 1: Table S1. Clinical characteristics of PD Patients with different serum phosphorus levels before and after propensity score matching (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, J., Li, W., Wang, Y. et al. Higher serum phosphorus predicts residual renal function loss in male but not female incident peritoneal dialysis patients. J Nephrol 33, 829–837 (2020). https://doi.org/10.1007/s40620-019-00670-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-019-00670-7

Keywords

Navigation